US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 13.690
  • +0.110+0.81%
Close Apr 26 16:00 ET
  • 13.690
  • 0.0000.00%
Post 17:05 ET
823.89MMarket Cap-1631P/E (TTM)

Sage Therapeutics Key Stats

Sage Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

Apr 25, 2024

Revenue(YoY)

7.90M

+139.89%
EPS(YoY)

-1.80

+26.83%

Hold

Apr 26, 2024

Sage Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.085M--
--2024/Q2-- / 8.288M--
Apr 25, 20242024/Q17.902M / 5.187M--
Feb 14, 20242023/Q477.972M / 60.976M--
Nov 7, 20232023/Q32.716M / 3.173M--
Aug 7, 20232023/Q22.474M / 2.914M--
May 2, 20232023/Q13.294M / 2.283M--
Feb 16, 20232022/Q42.865M / 1.940M--
Nov 8, 20222022/Q31.739M / 1.659M--
Aug 2, 20222022/Q21.501M / 1.769M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.085M--
--2024/Q2-- / 8.288M--
Apr 25, 20242024/Q17.902M / 5.187M--
Feb 14, 20242023/Q477.972M / 60.976M--
Nov 7, 20232023/Q32.716M / 3.173M--
Aug 7, 20232023/Q22.474M / 2.914M--
May 2, 20232023/Q13.294M / 2.283M--
Feb 16, 20232022/Q42.865M / 1.940M--
Nov 8, 20222022/Q31.739M / 1.659M--
Aug 2, 20222022/Q21.501M / 1.769M--

Unlock Free Earnings Estimates

Sage Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 26, 2024

Hold

  • Buy

    15.79%
  • Hold

    78.95%
  • Sell

    5.26%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg